Bifidobacterium in the treatment of inflammatory disease
CA 2359334 C · Owner: O'Sullivan, Gerald Christopher · Inventors: Shanahan, Fergus; Collins, John Kevin; O'Sullivan, Gerald Christopher
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption , in humans. The strain is useful in the prophylaxis and/or treatment of undesirable , inflammatroy activity, especially gastrointestinal inflammatory activity such as , inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity , may also be due to cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 17, 2000 and granted March 22, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.